The retailer’s EBITDA margin fell to 7.9% in Q3FY25 as compared to 8.5% in Q3FY24 while the PAT margin also decreased to 5% vs 5.5% on a YoY basis.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.